Cellectar Biosciences Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CALIGAN PARTNERS LP | 08/14/2026 | 470.00 K | $1.31 M | 100.00% | 3.84% |
| STEMPOINT CAPITAL LP | 08/14/2026 | 354.94 K | $986.73 K | 100.00% | 2.90% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 327.37 K | $910.08 K | 299.79% | 2.68% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/13/2026 | 321.73 K | $894.40 K | 100.00% | 2.63% |
| BLEICHROEDER LP | 08/13/2026 | 288.68 K | $802.53 K | 188.68% | 2.36% |
| JUPITER TOPCO LLC | 08/14/2026 | 274.16 K | $759.41 K | 100.00% | 2.24% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 220.00 K | $611.60 K | 100.00% | 1.80% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/19/2026 | 220.00 K | $611.59 K | 100.00% | 1.80% |
| EMPERY ASSET MANAGEMENT, LP | 08/11/2026 | 189.61 K | $527.10 K | 100.00% | 1.55% |
| DIADEMA PARTNERS LP | 08/14/2026 | 138.34 K | $384.59 K | 100.00% | 1.13% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 08/17/2026 | 104.55 K | $290.65 K | 100.00% | 0.85% |
| PERSISTENT ASSET PARTNERS LTD | 08/07/2026 | 92.98 K | $258.49 K | 100.00% | 0.76% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2026 | 85.07 K | $236.49 K | 100.00% | 0.70% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 53.35 K | $148.32 K | 1.09% | 0.44% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 46.22 K | $128.49 K | 178.89% | 0.38% |
| SEQUOIA FINANCIAL ADVISORS, LLC | 07/17/2026 | 21.85 K | $60.74 K | 15.92% | 0.18% |
| ACADIAN ASSET MANAGEMENT LLC | 08/13/2026 | 16.58 K | $46.00 K | 100.00% | 0.14% |
| NORTHERN TRUST CORP | 08/13/2026 | 14.84 K | $41.25 K | 100.00% | 0.12% |
| RIVERVIEW CAPITAL ADVISERS, LLC | 08/13/2026 | 10.38 K | $50.05 K | 0.00% | 0.08% |
| BLACKROCK, INC. | 08/07/2026 | 4.74 K | $13.16 K | -0.21% | 0.04% |
| UBS GROUP AG | 08/13/2026 | 3.09 K | $8.60 K | -67.94% | 0.03% |
| BARCLAYS PLC | 08/14/2026 | 561 | $1.56 K | 100.00% | 0.00% |
| MORGAN STANLEY | 08/13/2026 | 510 | $1.42 K | 0.00% | 0.00% |
| TD WATERHOUSE CANADA INC. | 07/27/2026 | 63 | $178 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 11 | $31 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 7 | $18 | 600.00% | 0.00% |
| US BANCORP \DE\ | 08/12/2026 | 3 | $8 | 0.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 08/14/2026 | 3 | $8 | 0.00% | 0.00% |
| DANSKE BANK A/S | 08/10/2026 | 2 | $6 | 0.00% | 0.00% |
| FMR LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 0 | $0 | -100.00% | 0.00% |
| WARBERG ASSET MANAGEMENT LLC | 08/11/2026 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cellectar Biosciences Inc institutional Ownership - FAQ's
During the previous two years, 47 institutional investors and hedge funds held shares of Cellectar Biosciences Inc. The most heavily invested institutionals were:
Caligan Partners LP: 469,998
StemPoint Capital LP: 354,938
VANGUARD CAPITAL MANAGEMENT LLC: 327,367
SILVERARC CAPITAL MANAGEMENT, LLC: 321,728
Bleichroeder LP: 288,679
Jupiter Topco LLC: 274,156
26.65% of Cellectar Biosciences Inc stock is owned by institutional investors.
Institutional investors have bought a total of 6.04 M shares in the last 24 months. This purchase volume represents approximately $16.61 M in transactions.